GlassScriptPhysician profile
Michael E Porvaznik
NPI 1689679482
$18,414.31
in general payments reported to CMS, 2019-2025
58 companies · $2,081 in 2025
The $2,081 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,133 · 2020: $2,802 · 2021: $2,830 · 2022: $2,946 · 2023: $3,090 · 2024: $2,533 · 2025: $2,081.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,703.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,683.50 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $1,621.26 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,546.92 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $1,546.08 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $1,386.08 | 2019-2025 | Repatha, Otezla, Evenity |
| Novartis Pharmaceuticals Corporation | $1,330.35 | 2019-2025 | |
| Lilly USA, LLC | $1,264.56 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $1,077.24 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $701.21 | 2019-2024 | Jardiance, Stiolto Respimat |
| Takeda Pharmaceuticals U.S.A., INC. | $671.98 | 2019-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $489.55 | 2022-2025 | Caplyta |
| Merck Sharp & Dohme LLC | $331.44 | 2019-2023 | Verquvo, Belsomra, Steglatro |
| Teva Pharmaceuticals USA, INC. | $314.66 | 2020-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $304.47 | 2019-2024 | Xifaxan, Cycloset |
| Eisai INC. | $299.40 | 2020-2023 |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $295.74 | 2019-2020 | |
| Astellas Pharma US INC | $292.25 | 2019-2025 | Veozah |
| Sanofi-Aventis U.S. LLC | $236.56 | 2020-2023 | |
| Axsome Therapeutics, INC. | $222.12 | 2023-2025 | Auvelity |
| Kowa Pharmaceuticals America, INC. | $176.35 | 2020-2022 | |
| Exact Sciences Corporation | $167.23 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $158.40 | 2023-2025 | |
| Amarin Pharma, INC. | $149.06 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $147.53 | 2021 | |
| Jazz Pharmaceuticals INC. | $145.47 | 2024-2025 | |
| Lundbeck LLC | $145.41 | 2022-2024 | Vyepti |
| Azurity Pharmaceuticals, INC. | $142.55 | 2023-2024 | Edarbi, Edarbi |
| Dexcom, INC. | $121.80 | 2023-2025 | Dexcom G6 Transmitter |
| Ironwood Pharmaceuticals, INC | $110.82 | 2019-2023 | Linzess |
| Neurocrine Biosciences, INC. | $105.35 | 2022-2024 | Ingrezza |
| Verona Pharma, INC. | $90.64 | 2025 | Ohtuvayre |
| E.R. Squibb & Sons, L.L.C. | $88.58 | 2019-2021 | |
| Abbott Laboratories | $87.27 | 2021-2025 | Freestyle Libre 3 |
| Biohaven Pharmaceutical Holding Company LTD. | $78.28 | 2022 | |
| Phathom Pharmaceuticals, INC. | $73.23 | 2024-2025 | Voquezna |
| Arbor Pharmaceuticals, INC. | $70.76 | 2019-2021 | |
| Xeris Pharmaceuticals, INC. | $68.54 | 2023-2025 | Keveyis |
| Vanda Pharmaceuticals INC. | $54.27 | 2024 | Fanapt |
| Upsher-Smith Laboratories LLC | $50.44 | 2020 | |
| Esperion Therapeutics, INC. | $45.72 | 2024-2025 | Nexletol |
| Amneal Pharmaceuticals LLC | $44.71 | 2020-2023 | Unithroid |
| Ironshore Pharmaceuticals INC. | $42.98 | 2020 | |
| Celgene Corporation | $40.84 | 2019 | |
| Ucb, INC. | $40.67 | 2023 | Briviact |
| Idorsia Pharmaceuticals US INC | $39.61 | 2022-2023 | Quviviq |
| Smith+Nephew, INC. | $36.50 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $34.46 | 2022-2023 | Spravato |
| Nestle Healthcare Nutrition INC. | $32.85 | 2022-2023 | |
| Almatica Pharma LLC | $30.92 | 2023-2024 | Loreev Xr, Teriparatide |
| Inari Medical, INC. | $30.35 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Antares Pharma, INC. | $28.94 | 2023 | Xyosted, Nocdurna, Tlando |
| 180 Medical, INC. | $26.59 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $21.30 | 2025 | Rexulti |
| Medtronic, INC. | $17.49 | 2025 | Venaseal |
| Shield Therapeutics INC | $16.19 | 2023 | Accrufer |
| Clarus Therapeutics INC. | $13.57 | 2021 | |
| Exeltis, USA INC. | $12.04 | 2021 | |
| Vbi Vaccine (Delaware) INC. | $11.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Porvaznik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.